跳至主要内容
临床试验/NCT01944488
NCT01944488Unknown不适用

LH Response to GnRH Test in Prepubescent Girls Under 6 Years

University of Aarhus1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2013年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
60
试验地点
1
主要终点
LH response

研究概览

简要总结

The project aims to establish the normal LH and FSH response to a standardized GnRH dose in healthy girls below 6 years of age, and compares the normal GnRH response to the GnRH response in girls with early puberty development.

The novel data may help to determine whether the girl is in early puberty or not.

Healthy girls under 6 years of age attending routine examinations including an i.v. line for other causes are included in this study. Our examinations also include bone age determination, Tanner stage determination, and anthropometric measures (height and weight). 10 healthy girls in each of the following age groups: 7-12 months, 12-24 months, 24-36 months, 36-48 months, 48-60 months and 60-72 months are included.

详细描述

Please refer to the brief summary which covers the study aim, methods and outcome measures.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
7 Months 至 6 Years(Child)
性别
Female
接受健康志愿者

入选标准

  • Endocrinologically healthy girls in the age from 7 months to 6 years
  • Obtained oral and written informed consent from participants parents

排除标准

  • Anamnestic, clinical or laboratory findings that indicate that the subject is suffering from other diseases (eg poorly controlled asthma) or is in a condition which might affect the subject's ability to complete the study or which is likely to affect the parameters under investigation.
  • Current medical treatment apart from prophylactic antibiotics or weak analgesics.
  • GFR <50 ml/min/1,73m2 or if absence of previous GFR study: serum creatinine above normal upper age-specific normal range.
  • Clinical signs of precocious puberty

研究组 & 干预措施

GnRH intervention

Experimental

All participating subjects are assigned to receive an intravenous GnRH agonist injection.

干预措施: GnRH agonist (Drug)

结局指标

主要结局

LH response

时间窗: 30 minutes

次要结局

  • FSH response(30 minutes)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验